|Institut National pour la Santé et la Recherche Biomédical|
|Maison de Solenn|
|97 boulevard du Port royal|
|75679 Paris cedex 14|
Prof. Bruno Falissard
Phone: +33 6818 270 76
Fax: +33 6818 270 76
Description of the organization
The Institut National pour la Santé et la Recherche Biomédicale (INSERM) is the French organisation dedicated to health research in France.
Prof. Falissard was the Principal Investigator of the MHP study (Mental Health in Prison, 2003‐2007). He has been and is co‐investigator/methodological advisor on more than 30 research projects that have led to publications in international peer reviewed journals.
Profile of staff members
Prof. Falissard is Professor in Public Health/Biostatistics at the South Paris University and has been the Head of the Public Health Department of Paul Brousse Hospital since 1999. Prof. Falissard was certified in Psychiatry in 1996, received his PhD in Biostatistics in 1990 and his degree from the “Ecole Polytechnique” in Paris in 1985. He has been the Head of INSERM U669 (PSIGIAM, Paris Sud Innovation Group in Adolescents Mental Health), a laboratory comprising of 110 members, since 2005. Prof. Falissard sits on the scientific boards of many foundations, as well as the Board of the International Journal of Methods in Psychiatric Research and is Statistical Advisor to the European Psychiatry Journal. He is past president of the scientific board of “Faculté de Médecine Paris‐Sud” and has co‐authored more than 130 papers indexed in the PubMed database.
Main tasks in the project
Prof. Falissard will assist the clinical WPs (5‐8), WP3 and WP4 in addressing the questions of design, data management and statistical analysis plans.
The fifth ADDUCE Newsletter is now available!
Here, you can read about the finalisation of the project,
the European Medicines Agency and General Assembly meetings
and the dissemination of the results!
The fourth ADDUCE Newsletter is available!
In this newsletter, you can find some information on the final recruitment status of the 2 main studies:
- the prospective open-label methylphenidate pharmacovigilance study
- the long-term cardiascular effects of methylphenidate use
Also, you can read about the future plans of the project!
More than 1500 children, adolescents and adults across all Europe already took part in our study! Thanks to them, we have already gathered lots of information so we can know a lot more about methylphenidate than ever before!
Did you participate in the ADDUCE studies and are you curious about the latest news on the project?
Here you can find some information!
News for children, April 2015
News for adolescents, April 2015
News for parents, April 2015
The third ADDUCE Newsletter is available!
- the prospective open-label methylphenidate pharmacovigilance study: recruitment status and spin-
- the long-term cardiovascular effects of methylphenidate use: study design and participation
and much more in the ADDUCE Newsletter 3, March 2015
WP3: prospective open-label methylphenidate
- WP8: long-term cardiovascular effects of methylphenidate use
and much more in the ADDUCE Newsletter 2, February 2013
16 - 19 OCTOBER 2016:
4rd EUNETHYDIS International Conference on ADHD, Berlin - Germany
from basis neuroscience to optimised clinical care
17 & 18 APRIL 2016:
ADDUCE Consortium meeting, London - UK
28 - 31 MAY 2015:
5th World Congress on ADHD: from Child to Adult Disorder, Glasgow - Scotland
20 & 21 APRIL 2015:
ADDUCE Consortium meeting, Salina - Italy
21 - 24 MAY 2014:
3rd EUNETHYDIS International Conference on ADHD, Istanbul - Turkey
ADHD and related disorders
19 & 20 MAY 2014:
ADDUCE Consortium meeting, Istanbul - Turkey
3 - 6 OCTOBER 2013:
23rd EUNETHYDIS Network Meeting, Prague Czech Republic
A meeting of the European Network of Hyperkinetic Disorders
6 - 9 JUNE 2013:
4th World Congress on ADHD: from Childhood to Adult Disease, Milan - Italy
4 & 5 JUNE 2013:
ADDUCE Consortium meeting, Milan - Italy
6 & 7 JUNE 2012:
ADDUCE Consortium meeting, Cagliari - Italy
23 MAY 2012:
2nd EUNETHYDIS International Conference on ADHD, Barcelona - Spain